Sphingolipid Biology and Regulation of Metabolism
$668,672ZIAFY2012DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Paper 35568252Paper 32029474Paper 31171507Paper 30683667Paper 30529276Paper 29383825Paper 29358305Paper 28100772Paper 27059959Paper 26268607Paper 26053123Paper 25954148Paper 25831442Paper 25829545Paper 25395622Paper 25351657Paper 25332431Paper 23637227Paper 22735358Paper 21642988Paper 21248243Paper 21173151Paper 20950672Paper 20407207Paper 20404103Paper 20097939Paper 19251691Paper 17311087
Abstract
The sphingolipid metabolic pathway is initiated by the incorporation of palmitoyl CoA, derivative of fatty acids, and ultimately provides substrates for the synthesis of other lipids. Thus the sphingolipid metabolic pathway is highly integrated with other dietary and structural lipid metabolic pathways. Furthermore, the sphingolipid metabolites themselves are bioactive and alter cell metabolism via signaling pathways. We have developed, and continue to develop genetically altered mice with modified expression of key sphingolipid enzyme activities in order to study the role of the pathway in metabolism including their role in diabetes and obesity.
View original record on NIH RePORTER →